ask="1.00"
ask_size="1500"
average_daily_volume="882032"
bid="0.95"
bid_size="2000"
book_value="0.61"
change="+0.00"
change_from_200_day_moving_average="-1.09"
change_from_50_day_moving_average="-0.05"
change_from_52_week_high="-3.98"
change_From_52_week_low="0.45"
change_in_percent="+0.00%"
close="0.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.24"
ebitda="-8.78M"
eps_estimate_current_year="-1.12"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.32"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.99"
high_52_weeks="4.93"
last_trade_date="3/1/2017"
last_trade_price="0.95"
last_trade_size="132"
last_trade_time="4:00pm"
low="0.95"
low_52_weeks="0.50"
market_capitalization="6.78M"
moving_average_200_day="2.04"
moving_average_50_day="1.00"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.33"
open="0.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-53.42%"
percent_change_from_50_day_moving_average="-4.97%"
percent_change_from_52_week_high="-80.73%"
percent_change_from_52_week_low="+90.00%"
previous_close="0.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.57"
price_per_sales="2.65"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.80"
stock_exchange="NCM"
symbol="OPXA"
volume="108649"
weeks_range_52="0.50 - 4.93"
